Abstract
Biological and psychosocial features influence the outcome of haloperidol treatment of multiple tic syndrome. Responders to haloperidol who have a family history of tics may suffer from a genetic and metabolic disorder, whereas nonresponders, who are inclined to perinatal abnormalities and have a later onset of tics, have an acquired disorder. Behavioral disturbances and psychosocial adaptation may influence or be influenced by drug usage. The hypothesis of uric acid metabolic abnormality was not supported but dopaminergic and/or γ-hydroxybutyrate neural systems may be implicated.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
